TNBC tumor cells lack estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER-2), making them unresponsive to standard hormonal and targeted therapies. This evidence concerns the gene ERBB2 and neoplasm.